文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

芬兰老年人流感疫苗效果评估及负对照结局残余混杂分析

Spotlight influenza: Estimation of influenza vaccine effectiveness in elderly people with assessment of residual confounding by negative control outcomes, Finland, 2012/13 to 2019/20.
PubMed 文献 · Euro Surveill · 2021-01-01

该研究基于芬兰2012/13至2019/20连续八个流感季节的注册数据,纳入约100万65-100岁人群,采用队列设计比较接种与未接种者实验室确诊流感的 hazard。疫苗效果范围为16%(95%CI:12-19)至48%(95%CI:41-54),负对照结局提示残余混杂可忽略,表明季节性流感疫苗接种可降低老年人重症流感风险。

要点

  • 65-100岁老年人接种流感疫苗可降低实验室确诊流感风险,效果随季节在16%至48%间波动。
  • 调整年龄、性别、接种史、既往住院夜数及慢性病后,负对照结局提示残余混杂可忽略。
  • 超过80%的实验室确诊流感病例需住院,提示疫苗对重症结局具有保护意义。

核心结论

  • 季节性流感疫苗接种可降低芬兰老年人重症流感疾病的 hazard。
  • 年龄、性别、接种史和住院服务利用数据足以控制混杂。

研究设计与样本

  • 基于芬兰常规注册数据的连续八个流感季节(2012/13至2019/20)的队列研究。
  • 每个分析队列约100万人,65-100岁,其中37%至49%已接种疫苗。
  • 疫苗效果以1减去经混杂调整的 hazard ratio 估计。

主要发现

  • 针对实验室确诊流感的疫苗效果范围为16%(95%CI:12-19)至48%(95%CI:41-54)。
  • 超过80%的实验室确诊病例住院。
  • 淡季急性呼吸道感染住院的调整 hazard ratio 估计在1.00(95%CI:0.94-1.05)至1.08(95%CI:1.01-1.15)之间。

临床怎么用

  • 可基于年龄、性别、接种史和住院利用数据评估老年人流感疫苗效果。
  • 负对照结局可用于评估观察性疫苗效果研究中残余混杂的充分性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundCohort studies on vaccine effectiveness are prone to confounding bias if the distribution of risk factors is unbalanced between vaccinated and unvaccinated study subjects.AimWe aimed to estimate influenza vaccine effectiveness in the elderly population in Finland by controlling for a sufficient set of confounders based on routinely available register data.MethodsFor each of the eight consecutive influenza seasons from 2012/13 through 2019/20, we conducted a cohort study comparing the hazards of laboratory-confirmed influenza in vaccinated and unvaccinated people aged 65-100 years using individual-level medical and demographic data. Vaccine effectiveness was estimated as 1 minus the hazard ratio adjusted for the confounders age, sex, vaccination history, nights hospitalised in the past and presence of underlying chronic conditions. To assess the adequacy of the selected set of confounders, we estimated hazard ratios of off-season hospitalisation for acute respiratory infection as a negative control outcome.ResultsEach analysed cohort comprised around 1 million subjects, of whom 37% to 49% were vaccinated. Vaccine effectiveness against laboratory-confirmed influenza ranged from 16% (95% confidence interval (CI): 12-19) to 48% (95% CI: 41-54). More than 80% of the laboratory-confirmed cases were hospitalised. The adjusted off-season hazard ratio estimates varied between 1.00 (95% CI: 0.94-1.05) and 1.08 (95% CI: 1.01-1.15), indicating that residual confounding was absent or negligible.ConclusionSeasonal influenza vaccination reduces the hazard of severe influenza disease in vaccinated elderly people. Data about age, sex, vaccination history and utilisation of hospital care proved sufficient to control confounding.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Baum U, Kulathinal S, Auranen K, et al. Spotlight influenza: Estimation of influenza vaccine effectiveness in elderly people with assessment of residual confounding by negative control outcomes, Finland, 2012/13 to 2019/20. Euro Surveill. 2021. PMID: 34505568. doi:10.2807/1560-7917.ES.2021.26.36.2100054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。